Torres A, Sáiz J, Sánchez A
Departamento de Farmacología, Facultad de Medicina, Córdoba, España.
Rev Esp Fisiol. 1987 Sep;43(3):310-5.
The chronic effect of two alpha-adrenergic receptor blockers, prazosin and yohimbine, on the renal noradrenaline (NA) content was investigated in two models of hypertensive rats, the DOCA-salt and the spontaneously hypertensive rats (SHR). In DOCA-salt rats an inversal relation exists between the level of blood pressure and renal NA content in all groups studied, except those treated with yohimbine and prazosin plus yohimbine. In SHR rats a decreased renal NA content has been detected with respect to their normotensive Wistar-Kyoto (WKY) rat controls. The administration of prazosin and/or yohimbine did not alter the renal NA content of the SHR rats, while on the contrary these agents produced an elevation of these levels in kidneys from normotensive WKY rats. These results suggest that the alpha-selective blocker agents used, demonstrate a different effect on the renal NA content in the two models of hypertension studied.
在两种高血压大鼠模型,即去氧皮质酮盐(DOCA-盐)大鼠和自发性高血压大鼠(SHR)中,研究了两种α-肾上腺素能受体阻滞剂哌唑嗪和育亨宾对肾脏去甲肾上腺素(NA)含量的慢性影响。在DOCA-盐大鼠中,除了用育亨宾以及哌唑嗪加育亨宾治疗的组外,所有研究组的血压水平与肾脏NA含量之间均存在反向关系。相对于正常血压的Wistar-Kyoto(WKY)大鼠对照,在SHR大鼠中检测到肾脏NA含量降低。给予哌唑嗪和/或育亨宾并未改变SHR大鼠的肾脏NA含量,而相反,这些药物使正常血压WKY大鼠肾脏中的这些水平升高。这些结果表明,所使用的α-选择性阻滞剂对所研究的两种高血压模型中的肾脏NA含量表现出不同的影响。